文献速递细胞病理与分子病理

细胞学诊断高分化神经内分泌肿瘤的准确性:美国病理学家学会非妇科玻片项目评估

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.
PubMed 文献 · Arch Pathol Lab Med · 2026-06-26

该研究分析美国病理学家学会非妇科细胞病理学教育项目中8941份对高分化神经内分泌肿瘤(WDNET)的细胞学诊断回应。参与者对“恶性”或“可疑恶性”的总体诊断选择率在 all 部位均超过90%,病理学家对WDNET的准确识别率在胰腺最高(91.3%),肺(79.0%)和肝(73.4%)较低,且病理学家在所有部位的诊断一致性均优于细胞技术人员(P < .001)。常见误诊包括胰腺腺癌、肺和肝的小细胞癌。

要点

  • 细胞学对WDNET的恶性判断敏感性高,但具体分型准确性存在部位差异。
  • 胰腺WDNET的细胞学诊断准确性最高,肝和肺较低。
  • 病理学家诊断一致性优于细胞技术人员,提示持续教育需求。

核心结论

  • 细胞学可识别WDNET,但诊断准确性仍有提升空间。
  • 病理学家对WDNET的诊断一致性优于细胞技术人员(P < .001)。

研究设计与样本

  • 研究队列为CAP非妇科细胞病理学教育项目中的非妇科细胞学玻片。
  • 共纳入1382个实验室的8941份回应,包括细胞技术人员和病理学家的个体回答。
  • 参考诊断包括胰腺神经内分泌肿瘤、肝高/中分化神经内分泌肿瘤、肺高/中分化神经内分泌肿瘤。

主要发现

  • 所有部位选择“恶性”或“可疑恶性”的总体诊断比例均超过90%。
  • 病理学家正确识别WDNET的比例:胰腺91.3%(2501/2738),肺79.0%(805/1019),肝73.4%(1444/1966)。
  • 病理学家在所有部位的诊断一致性均优于细胞技术人员(P < .001)。
  • 胰腺最常见错误回应为腺癌,肺和肝最常见误诊为小细胞癌。

临床怎么用

  • 细胞学诊断WDNET时需注意部位特异性误诊模式,胰腺警惕腺癌,肺和肝警惕小细胞癌。
  • 应加强细胞病理学教育以提升WDNET诊断准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT.—: The diagnosis and characterization of well-differentiated neuroendocrine tumors (WDNETs) on cytology is challenging, with recognized pitfalls that may have therapeutic and prognostic implications. OBJECTIVE.—: To analyze data curated by the College of American Pathologists educational slide program for accuracy in the cytologic diagnosis of WDNET. The current state of cytologic diagnosis of WDNET is also reviewed for educational purposes. DESIGN.—: The study cohort included non-gynecologic cytology slides reviewed by participants in the College of American Pathologists Non-Gynecologic Cytopathology Education program. Individual responses for cytotechnologists or cytologists (CT) and pathologists were collated for WDNET. The data were analyzed for concordance with the correct general diagnosis and concordance with the correct reference diagnosis. The exact reference diagnosis available for each site was "pancreatic neuroendocrine tumor," "liver, well/moderately differentiated neuroendocrine tumor," and "lung, well/moderately differentiated neuroendocrine tumor." Performance measures were assessed. RESULTS.—: The WDNET analysis includes 8941 responses from 1382 laboratories. The selection of the general diagnosis of "malignant" or "suspicious for malignancy" was greater than 90% in all body sites. Pathologists correctly identifying WDNET was highest in the pancreas (2501/2738, 91.3%) compared with the lung (805/1019, 79.0%) and liver (1444/1966, 73.4%). Pathologists had better concordance with the diagnosis of WDNET in all sites than CTs (P < .001). CONCLUSIONS.—: This large study, encompassing pathologists and CTs, confirms that although participants can identify WDNET on cytology, opportunities for greater accuracy and education persist. The most common incorrect response in the pancreas was adenocarcinoma, while the most common misdiagnosis was small cell carcinoma in the lung and liver.

来源:Arch Pathol Lab Med,查看原文。版权归原作者所有。

引用

  1. Crumley S, Souers R, Henry M, et al. Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program. Arch Pathol Lab Med. 2026. PMID: 42362197. doi:10.5858/arpa.2025-0638-CP

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。